Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1999 Apr 27;969:4797-802. doi: 10.1073/pnas.96.9.4797.
Show Gene links
Show Anatomy links
A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus egg extracts.
Rosania GR, Merlie J, Gray N, Chang YT, Schultz PG, Heald R.
???displayArticle.abstract???
Cellular differentiation is a complex process involving growth arrest, exit from the cell cycle, and expression of differentiated cell-type-specific functions. To identify small molecules promoting this process, a chemical library was screened by using a myeloid leukemic cell line that retained the potential to differentiate in culture. In the presence of a purine derivative, aminopurvalanol (AP), cells acquired phenotypic characteristics of differentiated macrophages and became arrested in the cell cycle with a 4N DNA content. AP also inhibited mitosis in Xenopus egg extracts, suggesting that it acted on an evolutionarily conserved cell cycle regulatory pathway. Affinity chromatography and biochemical reconstitution experiments with Xenopus egg extracts identified cyclin-dependent kinase (CDK) 1-cyclin B as a target of the compound. Although AP potently inhibited immunoprecipitates of both human CDK1 and CDK2 from human leukemic cell extracts, our results indicate that the compound preferentially targets the G2/M-phase transition in vivo.
Baghdassarian,
Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies.
1996, Pubmed
Baghdassarian,
Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies.
1996,
Pubmed Breitman,
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.
1980,
Pubmed Felix,
A post-ribosomal supernatant from activated Xenopus eggs that displays post-translationally regulated oscillation of its cdc2+ mitotic kinase activity.
1989,
Pubmed
,
Xenbase Gong,
Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines.
1994,
Pubmed Gorczyca,
Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays.
1993,
Pubmed Gray,
Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.
1998,
Pubmed Guadagno,
Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity.
1996,
Pubmed
,
Xenbase Hansen,
Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.
1989,
Pubmed Harris,
Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines.
1985,
Pubmed Heald,
Self-organization of microtubules into bipolar spindles around artificial chromosomes in Xenopus egg extracts.
1996,
Pubmed
,
Xenbase Hunter,
Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.
1994,
Pubmed Johnson,
Sequential protein kinase reactions controlling cell growth and differentiation.
1994,
Pubmed Lew,
Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast.
1991,
Pubmed Liu,
Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.
1996,
Pubmed Love,
Vitamin A, differentiation and cancer.
1994,
Pubmed Meijer,
Chemical inhibitors of cyclin-dependent kinases.
1997,
Pubmed Murray,
Cell cycle extracts.
1991,
Pubmed Murray,
The role of cyclin synthesis and degradation in the control of maturation promoting factor activity.
1989,
Pubmed
,
Xenbase Murray,
Cyclin synthesis drives the early embryonic cell cycle.
1989,
Pubmed
,
Xenbase Nigg,
Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle.
1995,
Pubmed Robles,
Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
1998,
Pubmed Rosenblatt,
Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A.
1992,
Pubmed Sawin,
Mitotic spindle assembly by two different pathways in vitro.
1991,
Pubmed
,
Xenbase Schutte,
The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
1997,
Pubmed Sidle,
Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
1996,
Pubmed Smythe,
Systems for the study of nuclear assembly, DNA replication, and nuclear breakdown in Xenopus laevis egg extracts.
1991,
Pubmed
,
Xenbase Stern,
A quantitative model for the cdc2 control of S phase and mitosis in fission yeast.
1996,
Pubmed
,
Xenbase Sundström,
Establishment and characterization of a human histiocytic lymphoma cell line (U-937).
1976,
Pubmed Tallman,
All-trans-retinoic acid in acute promyelocytic leukemia.
1997,
Pubmed Wilhelm,
Purification of recombinant cyclin B1/cdc2 kinase from Xenopus egg extracts.
1997,
Pubmed
,
Xenbase
